Product Code: MD 3684
Diabetes is a group of metabolic disorders, characterized by high blood glucose levels due to either inadequate insulin production or insulin resistance. Diabetes care devices are used to manage blood glucose levels. There are mainly two types of diabetes care devices, namely, blood glucose monitoring devices and insulin delivery devices. The BRIC diabetes care devices market is largely driven by the increasing number of diabetics across BRIC countries, growing research on diabetes, and increasing international research collaborations. The rising obese population and rapid industrialization and urbanization are further expected to contribute to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness inhibit the growth of this market.
In this report, the BRIC diabetes care devices market has been segmented by type into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices segment is further classified into testing strips, self-monitoring blood glucose meters, lancets, continuous glucose monitors, and others; while, the insulin drug delivery devices segment is subsegmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors.
The BRIC diabetes care devices market has witnessed strong growth in the past few years, and is further expected to grow at an approximate CAGR of 6.3% during the forecast period. Rising diabetic population in BRIC countries and growing adoption of diabetes care devices for management of diabetes and its complications by patients and healthcare professionals will propel the growth of the BRIC diabetes care devices market. China accounted for the largest share of this market in 2014; while, India is expected to witness the highest growth rate during the forecast period.
Some of the major players in this market include Becton, Dickinson and Company (U.S.), Roche Diagnostics Ltd. (Switzerland), Johnson and Johnson (U.S.), Bayer AG (Germany), Abbott Laboratories (U.S.), Acon Laboratories, Inc. (U.S.), Ypsomed AG (Switzerland), Novo Nordisk A/S (Denmark), Medtronic plc (Ireland), ARKRAY Inc. (Japan), Terumo Corporation (Japan), Dexcom, Inc. (U.S.), and Sanofi (France).
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below-mentioned strategies (market penetration, product development/innovation, and competitive assessment) for increasing their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the BRIC diabetes care devices market. The report analyzes the BRIC diabetes care devices market by type and country
- Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the BRIC diabetes care devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of the leading players in the BRIC diabetes care devices market
TABLE OF CONTENTS
1. INTRODUCTION
- 1.1. OBJECTIVES OF THE STUDY
- 1.2. MARKET DEFINITION
- 1.3. MARKET SCOPE
- 1.3.1. MARKETS COVERED
- 1.3.2. PRODUCT DESCRIPTION
- 1.3.2.1. Blood glucose monitoring devices
- 1.3.2.1.1. Self-monitoring blood glucose meters
- 1.3.2.1.2. Continuous glucose monitors (CGM)
- 1.3.2.1.3. Testing strips
- 1.3.2.1.4. Lancets
- 1.3.2.1.5. Other blood glucose monitoring devices
- 1.3.2.2. Insulin delivery devices
- 1.3.2.2.1. Insulin pumps
- 1.3.2.2.2. Insulin pens
- 1.3.2.2.3. Insulin syringes
- 1.3.2.2.4. Insulin jet injectors
- 1.3.3. YEARS CONSIDERED FOR THE STUDY
- 1.4. CURRENCY
- 1.5. LIMITATIONS
- 1.6. STAKEHOLDERS
2. RESEARCH METHODOLOGY
- 2.1. RESEARCH APPROACH
- 2.2. MARKET SIZE ESTIMATION
- 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.4. MARKET SHARE ESTIMATION
- 2.4.1. KEY DATA FROM SECONDARY SOURCES
- 2.4.2. KEY DATA FROM PRIMARY SOURCES
- 2.4.2.1. Key Industry Insights
- 2.5. ASSUMPTIONS
- 2.5.1. MARKET ASSUMPTIONS
- 2.5.2. PRICE ASSUMPTIONS
3. EXECUTIVE SUMMARY
4. PREMIUM INSIGHTS
- 4.1. GROWTH POTENTIAL OF THE BRIC DIABETES CARE DEVICES MARKET
- 4.2. BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET
- 4.3. DIABETES CARE DEVICES MARKET, BY GEOGRAPHY
- 4.4. CHINA TO DOMINATE THE DIABETES CARE DEVICES MARKET DURING THE FORECAST PERIOD
- 4.5. BRIC DIABETES CARE DEVICES MARKET
5. INDUSTRY INSIGHTS
- 5.1. TRENDS
- 5.1.1. GROWING DIABETES CARE MARKET IN INDIA
- 5.1.2. SHIFT TOWARDS CONTINUOUS GLUCOSE MONITORS
- 5.1.3. DEVELOPMENT OF NONINVASIVE GLUCOMETERS
- 5.2. TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY SYSTEMS
- 5.2.1. INSULIN INHALERS
- 5.2.2. ORAL INSULIN
- 5.2.3. ARTIFICIAL PANCREAS
- 5.2.4. INSULIN PATCHES/TRANSDERMAL INSULIN DELIVERY
6. BRAZIL: DIABETES CARE DEVICES MARKET
- 6.1. INTRODUCTION
- 6.2. MARKET DRIVERS
- 6.2.1. INCREASING INCIDENCE OF DIABETES ESPECIALLY AMONG OBESE POPULATION
- 6.2.2. INCREASED COLLABORATIONS AND FUNDING TO SUPPORT DIABETES RESEARCH
- 6.3. MARKET RESTRAINTS
- 6.3.1. LACK OF AWARENESS
- 6.3.2. GEOGRAPHICAL LIMITATIONS
- 6.4. MARKET OPPORTUNITIES
- 6.4.1. FAVORABLE GOVERNMENT POLICIES
- 6.5. MARKET CHALLENGES
- 6.5.1. STRINGENT REGULATIONS AND REGISTRATION PROCESS
- 6.6. MARKET SIZE
- 6.7. MARKET SHARE
7. RUSSIA: DIABETES CARE DEVICES MARKET
- 7.1. INTRODUCTION
- 7.2. MARKET DRIVERS
- 7.2.1. GROWTH IN AGING POPULATION
- 7.2.2. LARGE URBAN POPULATION AND RISING OBESITY
- 7.2.3. GROWING FOCUS OF MARKET PLAYERS TOWARDS RUSSIA
- 7.3. MARKET RESTRAINTS
- 7.3.1. HIGH COST OF DIABETES CARE DEVICES
- 7.3.2. DISPARITY IN REIMBURSEMENT
- 7.3.3. LARGE POOL OF UNDIAGNOSED PATIENTS
- 7.4. MARKET OPPORTUNITIES
- 7.4.1. GROWING AWARENESS ABOUT DIABETES
- 7.5. MARKET CHALLENGES
- 7.5.1. SHORTAGE OF HEALTHCARE PROFESSIONALS IN DIABETES MANAGEMENT
- 7.6. MARKET SIZE
- 7.7. MARKET SHARE
8. INDIA: DIABETES CARE DEVICES MARKET
- 8.1. INTRODUCTION
- 8.2. MARKET DRIVERS
- 8.2.1. INCREASING DIABETIC POPULATION
- 8.2.2. LIFE STYLE CHANGES DRIVING PREVALENCE OF DIABETES AMONG URBAN POPULATION
- 8.2.3. GROWING RESEARCH ON DIABETES AND ITS MANAGEMENT
- 8.3. MARKET RESTRAINTS
- 8.3.1. HIGH COST OF TREATMENT AND DEVICES
- 8.3.2. EMERGING ALTERNATIVE THERAPIES
- 8.3.3. LACK OF AWARENESS
- 8.4. MARKET OPPORTUNITIES
- 8.4.1. HUGE UNTAPPED MARKET POTENTIAL FOR DIABETES CARE DEVICES
- 8.5. MARKET CHALLENGES
- 8.5.1. PRICING PRESSURE FACED BY GLOBAL PLAYERS
- 8.6. MARKET SIZE
- 8.7. MARKET SHARE
9. CHINA: DIABETES CARE DEVICES MARKET
- 9.1. INTRODUCTION
- 9.2. MARKET DRIVERS
- 9.2.1. RISING DIABETIC POPULATION
- 9.2.2. INCREASING NUMBER OF INTERNATIONAL RESEARCH COLLABORATIONS
- 9.2.3. EXPANSION OF GLOBAL PLAYERS AND GROWING GOVERNMENT INITIATIVES
- 9.3. MARKET RESTRAINTS
- 9.3.1. HIGH COST OF TREATMENT AND DEVICES
- 9.3.2. TRADITIONAL CHINESE MEDICINE AS AN ALTERNATIVE
- 9.3.3. LOW REIMBURSEMENT FOR DIABETES CARE DEVICES
- 9.4. MARKET OPPORTUNITIES
- 9.4.1. IMPROVED PRIMARY CARE STRUCTURE
- 9.5. MARKET CHALLENGES
- 9.5.1. NONADHERENCE TO INTERNATIONAL STANDARDS AND GMPS BY LOCAL MANUFACTURERS
- 9.5.2. REGULATORY SCENARIO
- 9.6. MARKET SIZE
- 9.7. MARKET SHARE
10. COMPETITIVE LANDSCAPE
- 10.1. COMPETITIVE SITUATION AND TRENDS
- 10.1.1. EXPANSIONS
- 10.1.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
- 10.1.3. NEW PRODUCT LAUNCHES
11. COMPANY PROFILES (Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
- 11.1. ROCHE DIAGNOSTICS LIMITED
- 11.2. JOHNSON & JOHNSON
- 11.3. ABBOTT LABORATORIES
- 11.4. BAYER AG
- 11.5. MEDTRONIC PLC
- 11.6. BECTON, DICKINSON AND COMPANY
- 11.7. YPSOMED AG
- 11.8. NOVO NORDISK A/S
- 11.9. ARKRAY, INC.
- 11.10. SANOFI
- 11.11. ACON LABORATORIES, INC.
- 11.12. TERUMO CORPORATION
- 11.13. DEXCOM, INC.
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.
12. APPENDIX
- 12.1. INSIGHTS OF INDUSTRY EXPERTS
- 12.2. DISCUSSION GUIDE
- 12.3. AVAILABLE CUSTOMIZATIONS
- 12.4. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
- 12.5. RELATED REPORTS
LIST OF TABLES
- TABLE 1: BRAZIL: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT)
- TABLE 2: RUSSIA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT)
- TABLE 3: INDIA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT)
- TABLE 4: CHINA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT)
- TABLE 5: BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2014 (USD MILLION)
- TABLE 6: BRIC INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2014 (USD MILLION)
- TABLE 7: MARKET SHARES OF PLAYERS, 2014
- TABLE 8: LIST OF SOME NONINVASIVE GLUCOSE METERS
- TABLE 9: BRAZIL: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 10: BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 11: BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
- TABLE 12: BRAZIL: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 13: BRAZIL: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
- TABLE 14: RUSSIA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 15: RUSSIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 16: RUSSIA : BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
- TABLE 17: RUSSIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 18: RUSSIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
- TABLE 19: INDIA: DIABETES STATISTICS (2009-2013)
- TABLE 20: INDIA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 21: INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 22: INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
- TABLE 23: INDIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 24: INDIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
- TABLE 25: CHINA: DIABETES STATISTICS (2009-2013)
- TABLE 26: CHINA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 27: CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 28: CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
- TABLE 29: CHINA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
- TABLE 30: CHINA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
- TABLE 31: EXPANSIONS, 2012-2015
- TABLE 32: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015
- TABLE 33: NEW PRODUCT LAUNCHES, 2012-2015
LIST OF FIGURES
- FIGURE 1: RESEARCH DESIGN
- FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 3: BOTTOM-UP APPROACH
- FIGURE 4: TOP-DOWN APPROACH
- FIGURE 5: DATA TRIANGULATION METHODOLOGY
- FIGURE 6: DIABETIC POPULATION SIZE, 2013 AND 2035: GLOBAL VS. BRIC
- FIGURE 7: TESTING STRIPS HOLD LARGEST SHARE OF BLOOD GLUCOSE MONITORING DEVICES MARKET
- FIGURE 8: INSULIN PENS DOMINATE INSULIN DELIVERY DEVICES MARKET
- FIGURE 9: RISE IN DIABETIC POPULATION, INCREASING OBESITY TO DRIVE MARKET GROWTH
- FIGURE 10: CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET
- FIGURE 11: CHINA ACCOUNTED FOR ABOUT HALF OF THE BRIC DIABETES CARE DEVICES MARKET IN 2014
- FIGURE 12: DIABETES CARE DEVICES MARKET: GEOGRAPHIC MIX
- FIGURE 13: INDIA TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD
- FIGURE 14: GROWING DIABETES CARE MARKET IN INDIA AND SHIFT TOWARDS CONTINUOUS GLUCOSE MONITORS
- FIGURE 15: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2015 VS. 2020
- FIGURE 16: BRAZIL: DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
- FIGURE 17: RUSSIA: AGING POPULATION STATISTICS (2011-2050)
- FIGURE 18: LOW DIABETES DIAGNOSIS RATE: A MAJOR CONCERN IN RUSSIA
- FIGURE 19: RUSSIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
- FIGURE 20: CONTINUOUS GLUCOSE MONITORS ARE EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
- FIGURE 21: INDIA DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
- FIGURE 22: CHINA ACCOUNTED FOR NEARLY 1/4TH OF THE GLOBAL DIABETIC POPULATION IN 2013
- FIGURE 23: INSULIN PUMPS MARKET TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
- FIGURE 24: CHINA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
- FIGURE 25: COMPANIES ADOPTED EXPANSIONS AND AGREEMENTS AS THEIR KEY GROWTH STRATEGIES (2012-2015)
- FIGURE 26: BATTLE FOR MARKET SHARE: EXPANSIONS WAS THE KEY STRATEGY
- FIGURE 27: ROCHE DIAGNOSTICS LIMITED: COMPANY SNAPSHOT
- FIGURE 28: JOHNSON & JOHNSON: COMPANY SNAPSHOT
- FIGURE 29: ABBOTT LABORATORIES: COMPANY SNAPSHOT
- FIGURE 30: BAYER AG: COMPANY SNAPSHOT
- FIGURE 31: MEDTRONIC PLC: COMPANY SNAPSHOT
- FIGURE 32: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- FIGURE 33: YPSOMED AG: COMPANY SNAPSHOT
- FIGURE 34: NOVO NORDISK A/S: COMPANY SNAPSHOT
- FIGURE 35: SANOFI: COMPANY SNAPSHOT
- FIGURE 36: TERUMO CORPORATION: COMPANY SNAPSHOT
- FIGURE 37: DEXCOM, INC.: COMPANY SNAPSHOT
